Disc diffusion-based screening tests for extended-spectrum β-lactamases in Haemophilus influenzae

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 4, 2005, Pages 570-573

  Tristram, Stephen G ^a   Bozdogan, Bülent ^b   Appelbaum, Peter C ^b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

ESBLs; H. influenzae; TEM

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE INHIBITOR; CEFOTAXIME; CEFPODOXIME; CEPHALOSPORIN; CLAVULANIC ACID;

ANALYTIC METHOD; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; DIFFUSION; GENE EXPRESSION; HAEMOPHILUS INFLUENZAE; MOLECULAR CLONING; NONHUMAN; SCREENING TEST; VALIDATION PROCESS;

AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEFOTAXIME; CEFTIZOXIME; DOSE-RESPONSE RELATIONSHIP, DRUG; HAEMOPHILUS INFLUENZAE; MICROBIAL SENSITIVITY TESTS;

EID: 17444396781     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki036     Document Type: Article

References (12)

1. Dabernat, H., Delmas, C., Seguy, M. et al. (2002). Diversity of β-lactam resistance-conferring amino-acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrobial Agents and Chemotherapy 46, 2208-18.
2. Hoban, D. & Felmingham, D. (2002). The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. Journal of Antimicrobial Chemotherapy 50, Suppl. S1, 49-59.
3. Hasegawa, K., Yamamoto, K., Chiba, N. et al. (2003). Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microbial Drug Resistance 9, 39-46.
4. Bradford, P. (2001). Extended-spectrum β-lactamases in the 21st century: characterisation, epidemiology, and detection of this important resistance threat. Clinical Microbiology Reviews 14 933-51.
5. Tristram, S. (2003). Effect of extended-spectrum β-lactamases on the susceptibility of Haemophilus influenzae to cephalosporins. Journal of Antimicrobial Chemotherapy 51, 39-43.
6. ROB-1 mutations in hypermutagenic ΔampC Escherichia coli conferring resistance to cefolaxime and β-lactamase inhibitors and increased susceptibility to cefaclor. Antimicrobial Agents and Chemotherapy 47, 2551-7.
7. Pitout M., Macdonald K., Musgrave H. et al. (2002) Characterisation of extended spectrum β-lactamase (ESBL) activity in Haemophilus parainfluenzae. In Abstracts of the Forty-second Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 2002. Abstract C2-645, p. 96. American Society for Microbiology, Washington, DC, USA.
8. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fifth Edition: Approved Standard M7-A5. NCCLS, Villanova, PA, USA.
9. Matic, V., Bozdogan, B., Jacobs, M. et al. (2003). Contribution of β-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in β-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzae. Journal of Antimicrobial Chemotherapy 52, 1018-21.
10. National Committee for Clinical Laboratory Standards. (2000). Performance Standards for Antimicrobial Disk Susceptibility Tests - Sixth Edition: Approved Standard M2-A7. NCCLS, Villanova, PA, USA.
11. Andrews, J. M. (2001). BSAC standardized disc susceptibility testing method. Journal of Antimicrobial Chemotherapy 48, Suppl. S1, 43-57.
12. Bell, S., Gatus, B., Pham, J., et al. (2002). Antibiotic susceptibility Testing by the CDS Method a Manual for Medical and Veterinary Laboratories 2002. Arthur Productions Pty Ltd, Sydney, Australia.